<h3>Gainers</h3>
<ul>
<li>Cue Biopharma (NASDAQ:CUE) shares increased by 69.9% to $0.5 during Friday's regular session. The company's market cap stands at $28.6 million. </li>
<li>Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 32.14% to $5.18. The company's market cap stands at $26.8 million. </li>
<li>Tempest Therapeutics (NASDAQ:TPST) shares rose 30.37% to $2.06. The company's market cap stands at $22.6 million. </li>
<li>Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock rose 29.61% to $5.73. The market value of their outstanding shares is at $313.5 million. </li>
<li>Treace Medical Concepts (NASDAQ:TMCI) shares moved upwards by 20.58% to $1.84. The market value of their outstanding shares is at $97.4 million. </li>
<li>Organon (NYSE:OGN) stock moved upwards by 20.47% to $8.32. The market value of their outstanding shares is at $1.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CDT Equity (NASDAQ:CDT) shares declined by 23.8% to $4.49 during Friday's regular session. The market value of their outstanding shares is at $27.8 million. </li>
<li>Replimune Group (NASDAQ:REPL) stock declined by 19.46% to $4.76. The market value of their outstanding shares is at $463.6 million. </li>
<li>Harvard Bioscience (NASDAQ:HBIO) stock fell 16.39% to $4.49. The company's market cap stands at $24.0 million. </li>
<li>Insight Molecular (NASDAQ:IMDX) stock declined by 16.2% to $2.67. The company's market cap stands at $102.2 million. </li>
<li>Profusa (NASDAQ:PFSA) shares decreased by 16.09% to $0.88. The company's market cap stands at $1.4 million. </li>
<li>Virax Biolabs Group (NASDAQ:VRAX) shares decreased by 15.66% to $0.11. The market value of their outstanding shares is at $1.0 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

REPL

TPST

In Friday's trading session, Cue Biopharma saw a significant gain of 69.9%, reaching $0.5, while Plus Therapeutics and Tempest Therapeutics rose by 32.14% and 30.37%, respectively. Other notable gainers included Zentalis Pharmaceuticals and Treace Medical Concepts. Conversely, CDT Equity experienced the largest decline at 23.8%, followed by Replimune Group and Harvard Bioscience, which fell by 19.46% and 16.39%. Overall, the health care sector showed mixed performance with substantial movements in stock prices.

benzinga_article

Replimune

Tempest Therapeutics

SPDR S&P Biotech

Health Care Select Sector SPDR

First Trust NYSE Arca Biotech Index Fd

Cue BioPharma

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Harvard Bioscience

SPDR S&P Health Equip

Treace Medical Concepts

ALPS Medical Breakthrough

iShares US Medical Devices

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

VG Health

VanEck Biotech ETF

12 Health Care Stocks Moving In Friday's Intraday Session